Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1977-11-21
1978-12-12
Rosen, Sam
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
424177, A61K 3514, A61K 3516, A61K 3702
Patent
active
041296486
ABSTRACT:
A high molecular weight extract of mammalian blood plasma and serum proteins of the group Cohn fraction IV, Cohn subfraction IV.sub.1, IV.sub.4 and haptoglobin, have been found to contain activity which inhibits endogenous prostaglandin synthetase. This extract is therefore of utility in treating or alleviating pathological conditions associated with excessive or unbalanced snythesis of endogenous prostaglandins, for example, in reducing bronchoconstriction or treating arthritis. For this purpose, the extract may be administered by injection, by inhalation, or topically.
REFERENCES:
patent: 3920625 (1975-11-01), Andersson et al.
Collier Harry O. J.
Mannuzza Frank
Saeed Sheikh A.
Schneider Cyril
McNeil James D.
Rosen Sam
LandOfFree
Method for reducing endogenous prostaglandin synthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing endogenous prostaglandin synthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing endogenous prostaglandin synthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-831778